ME/CFS in the Department of Medicine

Herpes Viruses



Click on a title for more information

  1. Lerner AM et al. Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome. (2010)
  2. Lerner AM et al. Validation of the Energy Index Point Score to Serially Measure the Degree of Disability in Patients with Chronic Fatigue Syndrome. (2008)
  3. Lerner AM et al. Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up. (2007)
  4. White PD. What causes prolonged fatigue after infectious mononucleosis – and does it tell us anything about Chronic Fatigue Syndrome? (2007)
  5. Hickie I et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. (2006)
  6. Kogelnik et al. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. (2006)
  7. Okano et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. (2005)
  8. Lerner et al. Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome. (2004)
  9. Lerner et al. A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventrical function. (2002)


The information and opinions contained in this portion of the website are intended for educational and research purposes only. It is not intended for the medical management of patients and does not necessarily reflect the views of Stanford University or Stanford Hospital and Clinics.

Only a physician familiar with a patient's individual medical history can make medical judgments and give that patient specific medical advice.

Stanford Medicine Resources:

Footer Links: